Deciphering cellular states of innate tumor drug responses
-
* Corresponding author: Sandrine Imbeaud imbeaud@vjf.cnrs.fr
Genome Biology 2006, 7:R19 doi:10.1186/gb-2006-7-3-r19
Accesses
- Last 30 days: 48 accesses
- Last year: 865 accesses
- All time: 42049 accesses
Cited by
BioMed Central: 8 citations
|
Serges P Tsofack, Chantal Garand, Chris Sereduk, Donald Chow, Meraj Aziz, David Guay, Hongwei H Yin, Michel Lebel Molecular Cancer 2011, 10:145 (25 November 2011) |
|
Marla H Daves, Susan G Hilsenbeck, Ching C Lau, Tsz-Kwong Man BMC Medical Genomics 2011, 4:56 (7 July 2011) |
|
Vid Mlakar, Gašper Berginc, Metka Volavšek, Zdravko Štor, Miran Rems, Damjan Glavač BMC Cancer 2009, 9:282 (13 August 2009) |
|
Annie Glatigny, Hervé Delacroix, Thomas Tang, Nicolas François, Lawrence Aggerbeck, Marie-Hélène Mucchielli-Giorgi BMC Bioinformatics 2009, 10:98 (30 March 2009) |
|
Systems medicine: the future of medical genomics and healthcare Charles Auffray, Zhu Chen, Leroy Hood Genome Med 2009, 1:2 (20 January 2009) Systems approaches to medicine will transform the way drugs are developed and will enable medicine to become predictive, personalized, preventive and participatory.
|
|
Alison J Butt, C Marcelo Sergio, Claire K Inman, Luke R Anderson, Catriona M McNeil, Amanda J Russell, Marco Nousch, Thomas Preiss, Andrew V Biankin, Robert L Sutherland, Elizabeth A Musgrove Breast Cancer Research 2008, 10:R28 (29 March 2008) Transcript profiling identified an estrogen-responsive target for the mammary oncogene c-Myc, HSPC111, which is overexpressed in breast cancer cells and is associated with adverse patient outcome.
|
|
Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Alma Chavez-Blanco, Alma Revilla-Vazquez, Luis Benitez-Bribiesca, Alfonso Duenas-González Journal of Translational Medicine 2006, 4:32 (7 August 2006) |
|
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? Carlos Perez-Plasencia, Alfonso Duenas-Gonzalez Molecular Cancer 2006, 5:27 (10 July 2006) |